language_icon
EN
HI

Aspira Pathlab & Diagnostics Share price

ASPIRA

57

0.08 (-0.14%)
Last updated on 27 Feb, 2026 | 14:08 IST
Today's High

57.09

Today's Low

57.00

52 Week Low

50.49

52 Week High

106.78

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Aspira Pathlab & Diagnostics Chart

Aspira Pathlab & Diagnostics Share Key Metrics

Volume
559.00
Market Cap
58.75 CR
LTQ@LTP
1@57.00
ATP
57.07
Var Margin
27.3 %
Circuit Range
45.67-68.49
Delivery %
99.02 %
Value
31902.13
ASM/GSM
No
Market Lot
1

Summary

At 27 Feb, 2026 | 14:08, Aspira Pathlab & Diagnostics share price stands at ₹57, showing a 0.08% -0.14 for the day. The stock’s intraday movement has stayed between ₹57.00 and ₹57.09, while on a 52-week basis it has fluctuated from ₹50.49 to ₹106.78.
In terms of trading activity, Aspira Pathlab & Diagnostics has recorded a volume of 559 shares, with a market capitalisation of ₹10293000. The stock’s Average Traded Price (ATP) stands at ₹5707, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1,5700. The stock operates within a circuit range of ₹45.67-68.49, with a Value of ₹31902.13. The Delivery Percentage for the day is 99.02%. Additionally, Aspira Pathlab & Diagnostics currently falls under the No framework, and trades with a market lot size of 1.

Aspira Pathlab & Diagnostics Fundamentals

View More
P/E Ratio

24.46

P/B Ratio

4.64

Div. Yield

0

Sector P/E

55.37

Sector P/B

-16.06

Sec. Div. Yield

2.37

Aspira Pathlab & Diagnostics Resistance and Support

Pivot 58.04

Resistance

First Resistance

59.03

Second Resistance

60.99

Third Resistance

61.98

Support

First Support

56.08

Second Support

55.09

Third Support

53.13

Aspira Pathlab & Diagnostics Futures & Options

Data Not Found

Aspira Pathlab & Diagnostics Shareholding Pattern

View More
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

18.39%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

81.61%

Others

0%

Total Promoters
MAR '25
18.39%
JUN '25
18.39%
SEP '25
18.39%
DEC '25
18.39%

Aspira Pathlab & Diagnostics Corporate Actions

DateAgenda
2026-02-10Quarterly Results
2025-11-12Quarterly Results
2025-08-12Quarterly Results
2025-05-16Audited Results
2025-02-07Quarterly Results

Aspira Pathlab & Diagnostics News

No Data Found

About Aspira Pathlab & Diagnostics

NSE : 0  
BSE : 540788  
ISIN : INE500C01017  

Aspira Pathlab & Diagnostics Management

NamePosition
Dr. Haseeb A Drabu Chairman & Ind.Director
Dr. Pankaj J Shah Managing Director & CEO
View More

Aspira Pathlab & Diagnostics FAQs

The Buying Price of Aspira Pathlab & Diagnostics share is 57 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Aspira Pathlab & Diagnostics stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aspira Pathlab & Diagnostics, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Aspira Pathlab & Diagnostics shares is 24.46. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Aspira Pathlab & Diagnostics shares is 4.64. Useful to assess the stock's value relative to its book value.

To assess Aspira Pathlab & Diagnostics’s valuation compare Sector P/E, P/B which are 55.37 & -16.06 with sector averages, along with growth rates and financial metrics.

The Market Cap of Aspira Pathlab & Diagnostics is 58.75 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Aspira Pathlab & Diagnostics share price is 106.78 & 50.49. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Aspira Pathlab & Diagnostics belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost